Atlas FDA

Optune System

FDA premarket approval P100034/S019 · decided 2018-12-19

Approval details

PMA number
P100034
Supplement
S019
Supplement type
Real-Time Process
Supplement reason
Change Design/Components/Specifications/Material
Trade name
Optune System
Generic name
Stimulator, low electric field, tumor treatment
Applicant
Novocure, GmbH
Date received
2018-09-20
Decision date
2018-12-19
Days to decision
90 days
Decision code
APPR
Product code
NZK
Advisory committee
Neurology
Expedited review
No
Location
Baar
Statement
Approval for changes to Optune System carrying case and INE Transducer Array package sizes; Optune System software modifications increasing the secondary alarm threshold for INE Transducer Array partial attachment, correcting data transfer processing following switch from battery to mains power, and eliminating a redundant INE Transducer Array overheating alarm; and NovoTerminal software modifications improving Optune System data transfer processing.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.